Regencell Bioscience Holdings Ltd
Congressional Trades
Whale Activity
- Increased10
- New8
- Held4
- Decreased7
- Closed14
- No prior filing2
| Filer | Shares | Value | Change |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 423.4K | $2.6M | increased |
| Cerity Partners LLC | 128.7K | $801K | new |
| Legal & General Group Plc | 108.8K | $675K | decreased |
| JANE STREET GROUP, LLC | 81.7K | $508K | decreased |
| XTX Topco Ltd | 49.1K | $305K | decreased |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 43.1K | $268K | increased |
| MORGAN STANLEY | 40.6K | $252K | increased |
| GSA CAPITAL PARTNERS LLP | 38.9K | $242K | new |
| Savant Capital, LLC | 18.3K | $114K | new |
| Polar Asset Management Partners Inc. | 17.0K | $106K | new |
| CIBC Asset Management Inc | 15.3K | $95K | held |
| BlackRock, Inc. | 4,886 | $30K | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| CAMPBELL MICHAEL LDirector | Disposition to issuer | −703.7K | $23.00 | $16.2M | Feb 28, 2018 | Form 4 ↗ |
| YEMENIDJIAN ALEXDirector | Disposition to issuer | −21.9K | $23.00 | $503K | Feb 28, 2018 | Form 4 ↗ |
| TYRRELL JACKDirector | Disposition to issuer | −136.7K | $23.00 | $3.1M | Feb 28, 2018 | Form 4 ↗ |
| TYRRELL JACKDirector | Disposition to issuer | −100.0K | $23.00 | $2.3M | Feb 28, 2018 | Form 4 ↗ |
| TYRRELL JACKDirector | Disposition to issuer | −33.1K | $23.00 | $761K | Feb 28, 2018 | Form 4 ↗ |
| TYRRELL JACKDirector | Disposition to issuer | −10.4K | $23.00 | $240K | Feb 28, 2018 | Form 4 ↗ |
| THOMAS LEE MDirector | Disposition to issuer | −46.6K | $23.00 | $1.1M | Feb 28, 2018 | Form 4 ↗ |
| THOMAS LEE MDirector | Disposition to issuer | −33.2K | $23.00 | $763K | Feb 28, 2018 | Form 4 ↗ |
| THOMAS LEE MDirector | Disposition to issuer | −10.4K | $23.00 | $240K | Feb 28, 2018 | Form 4 ↗ |
| KEYTE DAVID HDirector | Disposition to issuer | −5,767 | $23.00 | $133K | Feb 28, 2018 | Form 4 ↗ |
| KEYTE DAVID HDirector | Disposition to issuer | −5,767 | $23.00 | $133K | Feb 28, 2018 | Form 4 ↗ |
| KEYTE DAVID HDirector | Disposition to issuer | −73.6K | $23.00 | $1.7M | Feb 28, 2018 | Form 4 ↗ |
| KAPLAN STEPHEN ADirector | Disposition to issuer | −161.0K | $23.00 | $3.7M | Feb 28, 2018 | Form 4 ↗ |
| Brymer Charles EDirector | Disposition to issuer | −75.8K | $23.00 | $1.7M | Feb 28, 2018 | Form 4 ↗ |
| BELL THOMAS D JRDirector | Disposition to issuer | −132.4K | $23.00 | $3.0M | Feb 28, 2018 | Form 4 ↗ |
| BRANDOW PETER BEVP, General Counsel, Sec. | Disposition to issuer | −236.5K | $23.00 | $5.4M | Feb 28, 2018 | Form 4 ↗ |
| Ownby DavidEVP, CFO and Treasurer | Disposition to issuer | −256.8K | $23.00 | $5.9M | Feb 28, 2018 | Form 4 ↗ |
| DUNN GREGORY WPresident and COO | Disposition to issuer | −98.4K | $23.00 | $2.3M | Feb 28, 2018 | Form 4 ↗ |
| MILES AMY EChief Executive Officer · Director | Disposition to issuer | −740.8K | $23.00 | $17.0M | Feb 28, 2018 | Form 4 ↗ |
| ANSCHUTZ PHILIP F10% owner | Disposition to issuer | −23.7M | — | — | Feb 28, 2018 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Invesco S&P Emerging Markets Momentum ETF Invesco Exchange-Traded Fund Trust II | 478 | $3K | 0.01% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list RGC's shares (CUSIP G7487R100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming Regencell Bioscience Holdings Ltd as the client.
Government Contracts
No federal contract awards found for Regencell Bioscience Holdings Ltd.
U.S. Patents
No USPTO patent applications found for Regencell Bioscience Holdings Ltd.
Annual Financials
SEC's XBRL figures for Regencell Bioscience Holdings Ltd include no full-year results from a 10-K in US dollars, so there is no table to show. Companies based abroad usually report annually on Form 20-F instead.
Stock Splits
- 38-for-1Stock splitJun 16, 2025
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
No 8-K filings on record.




